When is the earliest I can take NIPT during pregnancy?

NIPT (non-invasive prenatal testing) can be performed as early as 10 weeks of gestation. At this point, the fetal fraction of cell-free DNA in the mother's blood is typically high enough for accurate analysis.

Can I do carrier screening before I get pregnant?

Yes, carrier screening is often recommended before pregnancy. It can be done at any time—before conception, in the first trimester, or later—and tests for recessive conditions like cystic fibrosis and spinal muscular atrophy.

What is the difference between CVS and amniocentesis timing?

Chorionic villus sampling (CVS) is performed between 10 and 13 weeks, while amniocentesis is typically done between 15 and 20 weeks. Both are diagnostic procedures, but CVS cannot detect neural tube defects, which amniocentesis can.

When is the earliest I can take NIPT during pregnancy?

NIPT (non-invasive prenatal testing) can be performed as early as 10 weeks of gestation. At this point, the fetal fraction of cell-free DNA in the mother's blood is typically high enough for accurate analysis.

Can I do carrier screening before I get pregnant?

Yes, carrier screening is often recommended before pregnancy. It can be done at any time—before conception, in the first trimester, or later—and tests for recessive conditions like cystic fibrosis and spinal muscular atrophy.

What is the difference between CVS and amniocentesis timing?

Chorionic villus sampling (CVS) is performed between 10 and 13 weeks, while amniocentesis is typically done between 15 and 20 weeks. Both are diagnostic procedures, but CVS cannot detect neural tube defects, which amniocentesis can.

When Can You Do Genetic Testing During Pregnancy?

Learn the timing for NIPT, carrier screening, and other prenatal genetic tests in the US. Find out when to test and how to order a comprehensive panel.

Genetic testing during pregnancy can begin as early as 10 weeks with non-invasive prenatal testing (NIPT), also called cell-free DNA screening, which analyzes fetal DNA from a maternal blood draw. The exact timing depends on the type of test you choose—some, like carrier screening, can be done before pregnancy or in the first trimester, while diagnostic procedures such as chorionic villus sampling (CVS) are typically performed between 10 and 13 weeks. Understanding these windows helps you and your healthcare provider make informed decisions for your prenatal care in 2026.

Types of Prenatal Genetic Tests and Their Timing

First-Trimester Screening (10–13 Weeks)

First-trimester screening combines a blood test and an ultrasound (nuchal translucency) to assess risk for chromosomal conditions like Down syndrome. It is typically done between 10 and 13 weeks, with the ultrasound ideally performed at 11–13 weeks. This is a screening, not a diagnosis, and results are reported as risk scores.

NIPT (Non-Invasive Prenatal Testing) – From 10 Weeks

NIPT, or cell-free DNA testing, can be performed as early as 10 weeks of gestation. It analyzes small fragments of fetal DNA circulating in the mother’s blood to detect common trisomies (T21, T18, T13) and sex chromosome abnormalities. Fetal fraction—the proportion of fetal DNA in the sample—must be above a threshold (usually 4%) for accurate results, which is reliably achieved after 10 weeks. Many US providers offer NIPT from week 10 onward, and results typically return within 7–10 days.

Carrier Screening (Before or During Pregnancy)

Carrier screening can be done before conception or at any point in the first or second trimester. It tests both parents for recessive genetic conditions such as cystic fibrosis, spinal muscular atrophy, and fragile X syndrome. The American College of Obstetricians and Gynecologists recommends offering carrier screening to all patients, ideally before pregnancy, but it remains accurate when done during the first or early second trimester.

Quad Screen and Integrated Screening (15–22 Weeks)

The quad screen is a blood test performed between 15 and 22 weeks that measures four markers to assess risk for neural tube defects, Down syndrome, and trisomy 18. Integrated screening combines first-trimester results with quad screen data, requiring blood draws at two separate appointments (first at 10–13 weeks, second at 15–18 weeks). This approach improves accuracy but demands careful timing coordination.

Diagnostic Tests: CVS and Amniocentesis

Chorionic villus sampling (CVS): Performed between 10 and 13 weeks, CVS takes a small sample of placental tissue to diagnose chromosomal conditions. It carries a small risk of miscarriage (roughly 1 in 300–500 procedures) and is usually reserved for high-risk pregnancies or abnormal screening results.
Amniocentesis: Typically done between 15 and 20 weeks, amniocentesis samples amniotic fluid to diagnose genetic disorders and neural tube defects. The miscarriage risk is lower than CVS (about 1 in 500–1000). Both procedures require a genetic counselor to discuss risks and benefits beforehand.

Comparison of Test Timing and Purpose

Test Type	Gestational Window	What It Screens For
NIPT (cell-free DNA)	From 10 weeks	Trisomies 21, 18, 13; sex chromosome anomalies
Carrier screening	Before pregnancy or any trimester	Recessive conditions (CF, SMA, fragile X, etc.)
First-trimester screening	10–13 weeks	Risk for Down syndrome, trisomy 18
Quad screen	15–22 weeks	Neural tube defects, trisomies
CVS	10–13 weeks	Diagnostic for chromosomal disorders
Amniocentesis	15–20 weeks	Diagnostic for genetic and neural tube defects

How to Choose the Right Timing for You

Consult a Genetic Counselor

A genetic counselor can help you interpret your personal and family history to decide which tests are appropriate and when to take them. For example, if you have a family history of a specific condition, carrier screening may be recommended before pregnancy. If you are over 35, NIPT or diagnostic testing might be prioritized earlier.

Sequential vs. Integrated Screening

Some US clinics offer sequential screening, where first-trimester results are reported immediately, followed by second-trimester quad screen. Integrated screening withholds first-trimester results until the second blood draw, providing a single, highly accurate risk score. Discuss with your provider which approach aligns with your preferences for early information.

Special Considerations for 2026

Advances in cell-free DNA technology have expanded NIPT to screen for microdeletions and certain single-gene disorders, though not all panels include these. Fetal fraction remains a key metric—low levels (below 4%) may require a redraw or alternative testing. Additionally, prenatal paternity testing can be performed via NIPT from 9–10 weeks, but this is not a medical screening and is offered by separate labs. Always verify that your chosen panel includes the conditions most relevant to your ethnic background and family history.

If you are ready to take the next step, you can order a prenatal screening panel online and receive your results quickly, often within 7–10 business days, from a CLIA-certified lab serving the US market.